Recursion Pharmaceuticals shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Recursion Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Recursion Pharmaceuticals held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Recursion Pharmaceuticals by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $1.7M | 561k | 3.07 |
| 2025-12-31 | $1.7M | 415k | 4.09 |
| 2025-09-30 | $1.6M | 319k | 4.88 |
| 2025-06-30 | $1.4M | 282k | 5.06 |
| 2025-03-31 | $1.2M | 224k | 5.29 |
| 2024-12-31 | $893k | 132k | 6.77 |
| 2024-09-30 | $741k | 112k | 6.59 |
| 2024-06-30 | $661k | 88k | 7.50 |
| 2024-03-31 | $619k | 62k | 9.97 |
| 2023-12-31 | $558k | 57k | 9.86 |
| 2023-09-30 | $406k | 53k | 7.66 |
| 2023-06-30 | $574k | 77k | 7.47 |
| 2023-03-31 | $499k | 75k | 6.67 |
| 2022-12-31 | $585k | 76k | 7.71 |
| 2022-03-31 | $4.0M | 562k | 7.16 |
| 2021-12-31 | $15M | 858k | 17.13 |
| 2021-09-30 | $13M | 581k | 23.01 |
| 2021-06-30 | $21M | 583k | 36.50 |